Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
Fierce Biotech
Friday, December 20, 2024 - 11:26am
tags:
Cytokinetics, Sanofi, China, aficamten, heart disease, Corxel Pharmaceuticals
GSK posts mixed survival data for Jemperli/Zejula combo in first-line ovarian cancer
BioSpace
Friday, December 20, 2024 - 11:24am
tags:
GSK, Jemperli, Zejula, clinical trials, ovarian cancer
Idorsia's sale of Tryvio falls behind schedule, but layoffs remain on track
Fierce Biotech
Friday, December 20, 2024 - 11:22am
tags:
Idorsia, hypertension, Tryvio, layoffs
Boston Scientific updates cryoablation catheter instructions after 4 death reports
Medtech Dive
Friday, December 20, 2024 - 11:22am
tags:
Medtech, Boston Scientific, esophageal injury, cryoablation
Why the drug industry and its friends are holding their fire on RFK Jr.
Axios
Friday, December 20, 2024 - 11:20am
tags:
pharma industry, Robert F Kennedy Jr., Donald Trump, vaccines
Sorriso Pharma’s UC treatment hits Phase Ib endpoints
Clinical Trials Arena
Friday, December 20, 2024 - 11:18am
tags:
Sorriso Pharma, ulcerative colitis, clinical trials, SOR102
Neuralink rival Precision raises $102m, and other financings
Pharmaphorum
Friday, December 20, 2024 - 11:09am
tags:
Precision Neurosciences, funding, Neuralink, brain-computer interfaces
Apollomics, after giving up on GlycoMimetics' leukemia therapy, posts drug's latest phase 3 fail
Fierce Biotech
Friday, December 20, 2024 - 11:08am
tags:
Apollomics, China, AML, uproleselan
Zepbound, Mounjaro shortages are resolved, FDA confirms
BioPharma Dive
Thursday, December 19, 2024 - 9:36pm
tags:
FDA, Eli Lilly, Zepbound, Mounjaro, drug shortages
FDA rejects Zealand Pharma's GLP-2 analog in rare bowel disease
Fierce Biotech
Thursday, December 19, 2024 - 9:29pm
tags:
Zealand Pharma, glepaglutide, FDA, short bowel syndrome
Ionis Pharma's TRYNGOLZA Receives FDA Approval For Genetic Disorder Treatment
NASDAQ
Thursday, December 19, 2024 - 9:26pm
tags:
Ionis Pharmaceuticals, FDA, Tryngolza, hypertriglyceridemia
A venture firm breathes new life into an old NGM drug
BioPharma Dive
Thursday, December 19, 2024 - 9:23pm
tags:
KdT Ventures, NGM Biopharmaceuticals, NGM313
Medtech M&A Picked Up in 2024, But Belt-Tightening Continues
Medical Devices and Diagnostics Industry
Thursday, December 19, 2024 - 9:19pm
tags:
Medtech, M&A
Xcovery wins FDA approval for ALK inhibitor in NSCLC
First Word Pharma
Thursday, December 19, 2024 - 9:18pm
tags:
Xcovery, FDA, Ensacove, ALK inhibitors, non-small cell lung cancer
Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
Fierce Biotech
Thursday, December 19, 2024 - 11:31am
tags:
Regeneron, REGN7508, anticoagulants, enoxaparin, Eliquis, clinical trials
Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic
Fierce Biotech
Thursday, December 19, 2024 - 11:29am
tags:
Seagen, Ottimo Pharma, funding
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
BioSpace
Thursday, December 19, 2024 - 11:27am
tags:
Gilead Sciences, Assembly Bio, funding, hepatitis D
Vertex's pain trial hits endpoint but sinks stock as placebo comparison spooks investors
Fierce Biotech
Thursday, December 19, 2024 - 10:22am
tags:
Vertex Pharmaceuticals, suzetrigine, painkillers, non-opioid pain treatments
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
Stock Titan
Thursday, December 19, 2024 - 10:21am
tags:
Bristol Myers Squibb, BioArctic, BAN1503, BAN2803, Alzheimer's disease
Novartis to shutter 2 MorphoSys sites, lay off 330 staffers in post-buyout consolidation
Fierce Pharma
Thursday, December 19, 2024 - 10:11am
tags:
Novartis, MorphoSys, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.